Relanium en es it fr

Relanium Brand names, Relanium Analogs

Relanium Brand Names Mixture

  • No information avaliable

Relanium Chemical_Formula


Relanium RX_link

Relanium fda sheet

Relanium msds (material safety sheet)

Relanium MSDS

Relanium Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Relanium Molecular Weight

284.74 g/mol

Relanium Melting Point


Relanium H2O Solubility

Slightly soluble (50 mg/L)

Relanium State


Relanium LogP


Relanium Dosage Forms

Tablets; Injectable solution

Relanium Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Relanium Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Relanium Absorption

Essentially complete, with a bioavailability of 93%.

Relanium side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Relanium Patient Information

Relanium Organisms Affected

Humans and other mammals